These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3336085)

  • 1. Re: Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
    Bard RH
    J Urol; 1988 Jan; 139(1):145-6. PubMed ID: 3336085
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
    Epstein JI; Paull G; Eggleston JC; Walsh PC
    J Urol; 1986 Oct; 136(4):837-9. PubMed ID: 3761442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended follow-up of stage A1 carcinoma of prostate.
    Thompson IM; Zeidman EJ
    Urology; 1989 Jun; 33(6):455-8. PubMed ID: 2728146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental adenocarcinoma after open prostatic adenectomy.
    Stillwell TJ; Malek RS; Engen DE; Farrow GM
    J Urol; 1989 Jan; 141(1):76-8. PubMed ID: 2462068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of incidental prostatic carcinoma].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
    Epstein JI; Oesterling JE; Walsh PC
    J Urol; 1988 May; 139(5):980-4. PubMed ID: 3361676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
    Zincke H
    J Urol; 1994 Feb; 151(2):435. PubMed ID: 8283550
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term followup of young patients with stage A adenocarcinoma of the prostate.
    Blute ML; Zincke H; Farrow GM
    J Urol; 1986 Oct; 136(4):840-3. PubMed ID: 3761443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-pathological study on prostatic cancer, stage A using step section technic].
    Yushita Y; Minami Y; Sakuragi T; Kusaba Y; Kanetake H; Shindo K; Saito Y; Hara T; Tasaki T
    Hinyokika Kiyo; 1987 Aug; 33(8):1185-92. PubMed ID: 3425518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term followup results after expectant management of stage A1 prostatic cancer.
    Zhang G; Wasserman NF; Sidi AA; Reinberg Y; Reddy PK
    J Urol; 1991 Jul; 146(1):99-102; discussion 102-3. PubMed ID: 1711592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.
    Allen FJ; de Kock ML; de Klerk DP; Heyns CF
    S Afr J Surg; 1991 Mar; 29(1):15-8. PubMed ID: 1905062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
    Fujita T; Akino H; Kanimoto Y; Okada K; Shiraishi T; Nakakuki K
    Hinyokika Kiyo; 1991 Sep; 37(9):1009-16. PubMed ID: 1785407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the prostate: stage A1.
    Paulson DF
    Prog Clin Biol Res; 1987; 243B():329-32. PubMed ID: 3659029
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of untreated stage T1a prostate cancer.
    Cheng L; Neumann RM; Blute ML; Zincke H; Bostwick DG
    J Natl Cancer Inst; 1998 Jul; 90(14):1105-7. PubMed ID: 9672263
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of stage 1 carcinoma of the prostate.
    Varkarakis M; Castro JE; Azzopardi JG
    Proc R Soc Med; 1970 Jan; 63(1):91-3. PubMed ID: 5461434
    [No Abstract]   [Full Text] [Related]  

  • 19. Pattern of care and follow-up of stages A1, B1 prostatic cancers from multicenter group, the National Prostatic Cancer Treatment Group (NPCTG).
    Murphy GP; Gaeta J; Priore R
    Urology; 1987 Mar; 29(3):258-61. PubMed ID: 3824720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of prognosis in untreated stage A2 prostatic carcinoma.
    Mohler JL; Partin AW; Epstein JI; Becker RL; Mikel UV; Sesterhenn IA; Mostofi FK; Gleason DF; Sharief Y; Coffey DS
    Cancer; 1992 Jan; 69(2):511-9. PubMed ID: 1728382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.